Policy road map shows the way to end the overdose epidemic
It’s been clear for years that, to end the drug overdose epidemic, health insurance company and pharmacy benefit managers’ barriers to evidence-based treatment and non-opioid pain management must be eliminated.
Overdose epidemic requires state action to remove barriers to care
AMA, Mannatt report emphasizes the increasing importance of removing barriers to evidence-based care.
Patient Support & Advocacy
Help cut burdens of high-deductible health plans
These health plans mean lower premiums but higher patient cost-sharing, which can lead to and skipped care. AMA calls for innovative plan designs.
May 29, 2020: State Advocacy Update
New research highlights need to remove barriers for patients with opioid use disorder and more in the latest State Advocay Update.
State policy changes that can help COVID-19 fight
States can’t allocate trillions the way Congress can. Learn what state policymakers can do in the battle against the COVID-19 pandemic.
Feb. 14, 2020: National Advocacy Update
FTC & non-compete agreements, rules for Medicare Advantage networks and more in the latest AMA national health care advocacy news.
AMA statement on Ways and Means Committee surprise billing legislation
AMA supports underlying mechanism for resolving disputes, including the eligibility of all disputed claims for negotiation and mediation.
Membership Moves Medicine™
- Free access to JAMA Network™ and CME
- Save hundreds on insurance
- Fight for physicians and patient rights